Lori Firmani
CIK 1808248 · Chief Financial Officer · last filed 2026-01-06
Lori Firmani is a Chief Financial Officer who has filed 5 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing, for GLTO, was dated Jan 6, 2026. Across all open-market trades the lifetime net is −$5.7K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
5
-$5.7K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Damora Therapeutics, Inc. (GLTO) Delisted | Chief Financial Officer | 1,066 | $28.69 | $30.6K | -$4.9K | 4 | 2026-01-06 |
| F-star Therapeutics, Inc. (SBPH) Delisted | VP of Finance and Treasurer | 18,042 | — | — | -$833 | 1 | 2020-11-23 |
Recent Filings
5 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-06 | Damora Therapeutics, Inc. (GLTO) Delisted | Mixed | +239 | -$2.9K | EDGAR |
| 2025-07-08 | Damora Therapeutics, Inc. (GLTO) Delisted | Mixed | +227 | -$498 | EDGAR |
| 2025-01-07 | Damora Therapeutics, Inc. (GLTO) Delisted | Mixed | +465 | -$1.5K | EDGAR |
| 2024-10-11 | Damora Therapeutics, Inc. (GLTO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-11-23 | F-star Therapeutics, Inc. (SBPH) Delisted | Mixed | +16,075 | -$833 | EDGAR |